Can stroma reaction predict cancer lethality?

Can stroma reaction predict cancer lethality?
复制标题

DOI:
10.1158/1078-0432.ccr-13-1694
复制
发表时间:
2013-09-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
通讯作者:
Chung LW
Chung LW
中科院分区:
其他
文献类型:
--
作者:
Freeman MR;Li Q;Chung LW

文献摘要

被引文献

相似文献

肿瘤的间质特征可以提供一种相对一致的方法来对实体瘤患者进行分层。基质来源的转录组签名现在可以用来预测患者的生存,这表明它们在精确医学中临床应用的潜力,以预测疾病的进展和治疗耐药的出现。
Stromal features in carcinomas may provide a relatively consistent means to stratify patients afflicted with solid tumors. Stroma-derived transcriptome signatures can now be used to make predictions about patient survival, suggesting the potential for their clinical application in precision medicine to predict disease progression and emergence of therapeutic resistance.